Skip to main content
Fig. 4 | Diabetology & Metabolic Syndrome

Fig. 4

From: Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet

Fig. 4

Effects of EGCG on the gene expression and protein in FFAs-induced hepatocytes. A TG levels in hepatocytes; B effects of EGCG on protein expression of ACC1, FASn, PPAR–FGF21–AMPK; C quantification of Fig. B; D levels of FGFR2,FGFR3 and FGFR4 in hepatocytes; #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 vs BSA; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs FFA

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us